| Title |
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2021
|
| DOI | 10.1002/14651858.cd013825 |
| Authors |
Nina Kreuzberger, Caroline Hirsch, Khai Li Chai, Vanessa Piechotta, Sarah J Valk, Lise J Estcourt, Susanne Salomon, Eve Tomlinson, Ina Monsef, Erica M Wood, Cynthia So-Osman, David J Roberts, Zoe McQuilten, Nicole Skoetz |
Mendeley readers
The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 47 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 21% |
| Student > Master | 7 | 15% |
| Student > Bachelor | 5 | 11% |
| Student > Ph. D. Student | 4 | 9% |
| Other | 4 | 9% |
| Other | 6 | 13% |
| Unknown | 11 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 36% |
| Biochemistry, Genetics and Molecular Biology | 6 | 13% |
| Immunology and Microbiology | 6 | 13% |
| Nursing and Health Professions | 2 | 4% |
| Social Sciences | 2 | 4% |
| Other | 2 | 4% |
| Unknown | 12 | 26% |